H.R. 4534 — Reported in House

IB Union Calendar No. 520 118th CONGRESS 2d Session H. R. 4534 [Report No. 118–622] IN THE HOUSE OF REPRESENTATIVES July 11, 2023Mr. Boyle of Pennsylvania (for himself, Mr. Fitzpatrick, Ms. Blunt Rochester, Mr. Kilmer, Mr. Carbajal, and Mr. Raskin) introduced the following bill; which was referred to the Committee on Energy and Commerce July 30, 2024Additional sponsors: Ms. Pingree, Ms. Wasserman Schultz, Ms. Sewell, Ms. Houlahan, Ms. Moore of Wisconsin, Ms. Dean of Pennsylvania, Mr. Connolly, Ms. Clarke of New York, Ms. Wild, Mr. Rutherford, Mrs. Dingell, Ms. Kuster, Ms. Craig, Mrs. Trahan, Mr. David Scott of Georgia, Ms. Kelly of Illinois, Mr. Bacon, Ms. Stefanik, Mrs. González-Colón, Mr. Lawler, Ms. Castor of Florida, Mr. Ruiz, Mr. Cárdenas, Ms. Norton, Mr. Ciscomani, Mr. Evans, Mr. Doggett, Mrs. Fletcher, Mr. Van Drew, and Mr. Nunn of Iowa July 30, 2024Reported with an amendment, committed to the Committee of the Whole House on the State of the Union, and ordered to be printedStrike out all after the enacting clause and insert the part printed in italicFor text of introduced bill, see copy of bill as introduced on July 11, 2023 A BILL To require a review of women and lung cancer, and for other purposes. 1. Short title This Act may be cited as the Women and Lung Cancer Research and Preventive Services Act of 2024. 2. Interagency review to evaluate and identify opportunities for the acceleration of research on lung cancer in women and underserved populations, greater access to preventive services, and strategic public awareness and education campaigns (a) In general The Secretary of Health and Human Services, in consultation with the Secretary of Defense and Secretary of Veterans Affairs, shall conduct an interagency review to evaluate the status of, and identify opportunities related to— (1) research on lung cancer in women; (2) research on lung cancer in underserved populations that meet the eligibility criteria for lung cancer screening as recommended by the United States Preventive Services Task Force; (3) access to lung cancer preventive services; and (4) strategic public awareness and education campaigns on lung cancer. (b) Content The review and recommendations under subsection (a) shall include— (1) a review and comprehensive report on the outcomes of previous research, the status of existing research activities, and knowledge gaps related to lung cancer in women and underserved populations in all agencies of the Federal Government; (2) opportunities for collaborative, interagency, multidisciplinary, and innovative research, that would— (A) encourage innovative approaches to eliminate knowledge gaps in research on lung cancer in women; (B) evaluate environmental and genomic factors that may be related to the etiology of lung cancer in women; and (C) foster advances in imaging technology and techniques to improve risk assessment, diagnosis, treatment, and the simultaneous utilization of other preventive services and activities; (3) opportunities regarding the development of a national lung cancer screening strategy to expand access to such screenings, particularly among women and underserved populations; and (4) opportunities regarding the development of a national public education and awareness campaign on— (A) lung cancer in women and underserved populations; and (B) the importance of early detection of lung cancer. (c) Report Not later than two years after the date of the enactment of this Act, the Secretary of Health and Human Services shall submit to Congress a report on the review conducted under subsection (a). July 30, 2024Reported with an amendment, committed to the Committee of the Whole House on the State of the Union, and ordered to be printed